Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patients
Abstract Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease characterized by a microangiopathy and fibrosis of the skin and internal organs. No treatment has been proved to be efficient in case of early or advanced SSc to prevent or reduce fibrosis. There are strong arguments fo...
Main Authors: | J. Lapoirie, L. Tran, L. Piazza, C. Contin-Bordes, M. E. Truchetet, F. Bonnet |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-97538-3 |
Similar Items
-
P-glycoprotein-dependent pharmacokinetics of irinotecan and its active metabolite, SN-38 in rats: Effect of verapamil
by: Tripta Garg, et al.
Published: (2015-03-01) -
Metabolite analysis of human dermal fibroblasts
by: Ting, Lee Yu, et al.
Published: (2014) -
Phosphatidylserine prevents UV-induced decrease of type I procollagen and increase of MMP-1 in dermal fibroblasts and human skin in vivo
by: Soyun Cho, et al.
Published: (2008-06-01) -
Fermentation of Panax notoginseng root extract polysaccharides attenuates oxidative stress and promotes type I procollagen synthesis in human dermal fibroblast cells
by: Shiquan You, et al.
Published: (2021-01-01) -
5-Fluorouracil and irinotecan (SN-38) have limited impact on colon microbial functionality and composition in vitro
by: Eline Vanlancker, et al.
Published: (2017-11-01)